Skip to content

Xtant Medical Holdings XTNT Deferred Tax Assets, Valuation Allowance

Deferred Tax Assets, Valuation Allowance at other companies

Cineverse Corp. logo
Cineverse Corp.CNVS
$31.36M+0.7%
Envoy Medical logo
Envoy MedicalCOCH
$654K+2.5%
State Street logo
State StreetSTT
$198M+15.1%
OFG Bancorp logo
OFG BancorpOFG
$568K-87.9%
BK
BKBK
$127M-5.9%
PepsiCo logo
PepsiCoPEP
$6.12B-1.1%

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsValuationAllowance.

The official record: Xtant Medical Holdings’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's deferred tax assets, valuation allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's deferred tax assets, valuation allowance?
Xtant Medical Holdings (XTNT) reported deferred tax assets, valuation allowance of $18.18M in Q4 2025.
How has Xtant Medical Holdings's deferred tax assets, valuation allowance changed year-over-year?
Xtant Medical Holdings's deferred tax assets, valuation allowance decreased by 37.2% year-over-year, from $28.95M to $18.18M.
What is the long-term trend for Xtant Medical Holdings's deferred tax assets, valuation allowance?
Over 5 years (2020 to 2025), Xtant Medical Holdings's deferred tax assets, valuation allowance has grown at a -0.8% compound annual growth rate (CAGR), from $18.97M to $18.18M.